TACR1 and COVID-19: I would like to mention one of our most recent clinical trials in which we have found that NK-1R antagonist aprepitant in combination with dexamethasone may improve the recovery of coronavirus disease 2019 (COVID-19) patients by improving respiratory recovery (Sha et al., 2017).